Investors want Chamath Palihapitiya ETF and they could get it soon



[ad_1]

TipRanks

These 3 “Strong Buy” stocks are the best choices for 2021, analysts say

Some traditions are too old to slip away, and on Wall Street, the annual “best picks” are one of them. Usually done at the very end or beginning of a year, Street analysts post reviews of the stocks they think will perform best in the coming months – their top picks. Analysts have carefully analyzed each stock, looking at its past and current performance, trends over a variety of time frames, management’s plans – they take everything into account. Their recommendations provide valuable direction for building a resilient portfolio in the New Year. With that in mind, we used TipRanks’ database to identify three stocks that analysts describe as their “top picks” for 2021. Talos Energy (TALO) The Gulf of Mexico has long been known as one of the great regions. production of hydrocarbons in the world, and Talos Energy, which produces approximately 48,000 barrels of oil equivalent per day from offshore operations in the Gulf, is a major player in the region. Talos ended the third quarter of 2020 with a net loss, but revenue, at $ 135 million, increased 53% sequentially. The company reported more than $ 353 million in available cash at the end of the quarter, including $ 32 million in cash and $ 321 million in available credit. In December of last year, and continuing through January, Talos strengthened its liquidity position through issuance of senior secured notes. The December issue, in the amount of $ 500 million at 12%, will primarily be used to repay a previous issue of notes that will mature next year. The January issue of an additional $ 100 million will be used to cover outstanding debt on the reserve-based lending facility. Both rating issues are due in 2026. Highlighting TALO as its top E&P pick for 2021, Northland analyst Subash Chandra wrote, “TALO is one of the few companies that we are aware of trading at lower PDP values. for no reason, in our opinion. The company resolved the issue of the maturity wall and credit facilities with a stock offering and refinancing in December. They enter 2021 with leeway to cross the finish line with Zama and seek out scale-up opportunities in GoM. “To that end, Chandra credits TALO with an outperformance (i.e. a buy) and sets a price target of $ 19, indicating growth potential of 91% in the coming months. (To see Chandra’s track record, click here) Overall, with five analyst reviews on file, including 4 buys and a single Hold, Talos gets a Strong Buy rating from analyst consensus. Shares are priced at $ 9.96 and their average target of $ 14.33 is roughly 44% up over a year. (See TALO stock market analysis on TipRanks) Twilio (TWLO) Next, Twilio, a cloud communications company from Silicon Valley. Twilio’s software services allow customers to run their telecommunications service through their office computer servers, making available not only phone calls, but also chats, text messages and video chats. The service includes features security such as user verification. The COVID pandemic and the shift to remote working that has been forced on the economy has been a boon for Twilio. The shift focused on stable and reliable remote connections and teleworking, and the company’s revenue, which was already strong and showing sequential gains each quarter, hit $ 447 million in 3Q20. Subsequently, Twilio shares have soared 225% in the past 52 weeks. Oppenheimer analyst Ittai Kiddron sees the company on a solid footing for continued growth, writing: “While some put options are in place in 1Q21, Twilio’s long-term opportunity remains underestimated by Investors. We believe that the company’s differentiated product portfolio (communications / data) and its scalable GTM approach (hiring / GSI) can drive G2K / international adoption / expansion and enable> 30% turns. large-scale growth (> $ 4B / $ 6B) up to CY23 / 24. “The 5-star analyst chooses TWLO as” first choice, “based on his optimistic analysis of Twilio. It comes with a rating. outperformance (i.e. Buy) and a price target of $ 550 implying one-year growth of 41%. (To see Kiddron history click here) How Kiddron’s bullish bet weighs Overall, Wall Street loves Twilio, a clear fact from 21 analyst reviews recorded. No less than 18 of these are buys, compared to just 3 takes. , the stock’s recent stock gains have pushed the price to $ 388.65, leaving room only 2% higher before reaching the average price target of $ 396.88. (See TWLO stock market analysis on TipRanks) SI-Bone (SIBN) Medical technology is an area of ​​almost endless possibilities, and SI-Bone has found a niche. The company specializes in diagnosing treatment in s able of pain and dysfunction of the sacroiliac joint between the lower back and the pelvis. Company revenues fell between 4Q19 and 2Q20 as the corona crisis hampered elective medical procedures. This turned around in the third quarter, when the economy started to open up; many industries, including the medical field, have experienced an explosion in pent-up demand that has yet to dissipate. In gross numbers, SIBN reported a sequential 42% increase in revenue for the third quarter, with revenue of $ 20.3 million. Year over year, revenues increased 26%. During the quarter, the company completed 50,000 iFuse procedures, processed by 2,200 surgeons around the world. The company had $ 132 million in liquid assets at the end of the quarter, compared to $ 39.4 million in long-term debt. Going forward, the company is moving towards an 8% to 10% year-over-year increase in revenue for the year 2020, expecting revenue of $ 73 million to $ 74 million. . Analyst David Saxon, covering the action of Needham, said: “SIBN has been resilient during the pandemic and we believe its growth drivers may allow it to beat consensus revenue throughout 2021 Training of surgeons, upcoming product launches, and direct marketing to patients will all contribute significant revenues over the next several years. Saxon uses these points to support its “first choice” status for SIBN. Her average price target is $ 35, which suggests a 23% hike and fits her buy rating perfectly. (To see Saxon’s record, click here) Overall, SI-Bone gets a strong buy from Wall Street, and it’s unanimous – based on 5 positive reviews. The stocks are selling for $ 28.48, and their average target of $ 33.80 implies a room for growth of around 19% during 2021. (See SIBN’s stock market analysis on TipRanks) stocks at attractive valuations, visit Top TipRanks Stocks for Buy, a newly launched tool that brings together all the information about TipRanks stocks. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

[ad_2]

Source link